Abstract A unique and simple calorimetric method for the quantitation of plasma protamine levels has been developed. The method is established on the competitive binding displacement mechanism between protamine and heparin-azure A dye complex, and the metachromatic color change of azure A dye in the presence of heparin. Because the method is based on the clinical specificity of protamine as the heparin antagonist, it is specific for protamine quantitation. Plasma protamine levels determined by this method are within 94% of accuracy when compared with their aqueous counterparts determined by the conventional Lowry protein assay. Since the method measures the protamine excess after heparin neutralization, it potentially could be employed during clinical heparin reversal with protamine to monitor protamine excess. In addition, the method may provide a useful means to identify the mechanism of the so-called "heparin rebound".
metachromatic shift of the dye's absorption maximum from 620 (blue) to 530 mu (purple) (6) . The binding is, however, reversible and relatively weak compared to that between heparin and protamine. Thus when protamine is present, it will bind to heparin and displace a certain portion of the dye from the heparin-azure A complex. absorption Once the dye is dissociated from heparin, its maximum immediately shifts back to the initial wavelength of 620 mu. The degree of dye displacement is linearly proportional to the pmtamine concentration in the sample. Therefore, by adding the test plasma sample to an assay mixture containing heparin-azure A dye complexes and then measuring the absorbance at 620 nm, the protamine content in the sample can be precisely determined from a pm-constructed standard curve.
Determined in this study is the sensitivity and accuracy of the method for pro&mine quantitation, as well as the effect of sample variation on the slope of the standard curve. In addition, by adding protamine to an already heparinized plasma sample, we here examined whether the method measures the total protamine content or the "protamine excess" after heparin neutralization.
MATERIALS AND METHODS
Liquid commercial heparin (1000 units/ml) was obtained from Elkins-Sinn (Cherry Hill, NJ). This heparin was from porcine intestinal mucosa, and possessed an average molecular weight of 11,500 daltons and a specific activity of 165 USP units/mg. Protamine sulfate (Clupeine, from Herring) and the Folin-phenol reagent for the Lowry protein assay were purchased from Sigma Chemical Co. (St. Louis, MO). The dye reagent required for the Bradford protein assay was purchased from Bio-Rad Laboratories (Richmond, CA). Azure A dye (A-970, lot 741002) was from Fisher Scientific Co. (Fair Lawn, NJ). Actin (activated cephaloplastin reagent) for the aPlT assay was from Dade (Miami, FL). The aPTT assay was performed using the procedures described previously (7) . Freshly frozen titrated (CPD) human plasma was obtained from the American Red Cross (Detroit, MJ), and was stored at -44PC prior to its use. Water was distilled and de-ionized. Unless otherwise stated, all experiments were conducted at mom temperature (20 + 1oC) and each experiment was performed in triplicate.
Construction of Standard Curves.
Assay solutions containing 80 &nL of azure A dye and 3.3,5,10,15 units/mL of heparin were prepared by the addition of adequate amounts of azure A dye and heparin to distilled water. These heparin-dye assays solutions, when stored refrigerated, remain stable for a period of at least three months. From each assay solution, aliquots of 600 ~.LL were drawn and transferred to a sequence of polypropylene tubes. To each tube, 400 tiL of plasma containing increasing amounts of protamine were added. The absorbance in each tube was then measured at 620 ~1 against the reference sample which contained the same amount of heparin and azure A dye but no protamine. The standard curves thus prepared with final heparin concentrations of 2,3,6, and 9 units/ml were defined as the "2-", "3-", " 6-l', and "9~unit standard,,, respectively.
Valiabtion of the Method for Protamine Quantitation.
Two sets of test samples parallel in protamine concentrations ranging from 25 to 250 ug/mL were prepared from the same protamine stock solution (6 m@nL) using adequate dilutions. These two sets of samples were prepared in exactly the same way except that one set utilized water and the other set utilized plasma as the dilution vehicle. Protamine concentrations in aqueous samples were then determined by the Lowry method (4)' while protamine concentrations in plasma samples were determined by the dye method, Each concentration measurement was performed in triplicate. To perform the dye method, 400 uL of test samples with protamine concentrations in the range of O-40,40-90,90-175, and 175-250 ug/mL were added to 600 uL assay solutions containing 3.3,5, 10, and 15 units/ml of heparin, respectively. All the assay solutions contained 80 t.&nL of azure A dye. Protamine concentrations in the above four concentration ranges were then determined using the "2-", "3-" "6-", and "9-unit" standard curves, respectively. Both the test protamine , samples and the standard curves were prepared with plasma obtained from the same donor. The two protamine quantitation methods were compared statistically using the method-comparison procedures described by Westgard and Hunt (8) . Linear regression analysis was performed to metachromatic shift of the dye's absorption maximum from 620 (blue) to 530 nm (purple) (6) . The binding is, however, reversible and relatively weak compared to that between heparin and protamine. Thus when protamine is present, it will bind to heparin and displace a certain portion of the dye from the heparin-azure A complex. Once the dye is dissociated from heparin, its absorption maximum immediately shifts back to the initial wavelength of 620 nm. The degree of dye displacement is linearly proportional to the protamine concentration in the sample. Therefore, by adding the test plasma sample to an assay mixture containing heparin-axure A dye complexes and then measuring the absorbance at 620 nm, the protamine content in the sample can be precisely determined from a preconstructed standard curve.
Determined in this study is the sensitivity and accuracy of the method for protamine quantitation, as well as the effect of sample variation on the slope of the standard curve. In addition, by adding protamine to an already heparinixed plasma sample, we here examined whether the method measures the total pmtamine content or the "protamine excess" after heparin neutralization.
MATERIALS AND METHODS
Liquid commercial heparin (lo00 units/ml) was obtained from Elkins-Sinn (Cherry Hill, NJ). This heparin was from porcine intestinal mucosa, and possessed an average molecular weight of 11,500 daltons and a specific activity of 165 USP units/mg. Protamine sulfate (Clupeine, from Herring) and the Folin-phenol reagent for the Lowry protein assay were purchased from Sigma Chemical Co. (St. Louis, MO). The dye reagent required for the Bradford protein assay was purchased from Bio-Rad Laboratories (Richmond, CA). Azure A dye (A-970, lot 741002) was from Fisher Scientific Co. (Fair Lawn, NJ). Actin (activated cephaloplastin reagent) for the aP'lT assay was from Dade (Miami, FL). The aPTT assay was performed using the procedures described previously (7) . Freshly frozen titrated human plasma was obtained from the American Red Cross (Detroit, MI), and was stored at -4ooc prior to its use. Water was distilled and deionized. Unless otherwise stated, all experiments were conducted at room temperature (20 + 1eC) and each experiment was performed in triplicate.
Construction of Standard Curves.
Assay solutions containing 80 ug/mL of azure A dye and 3.3,5,10,15 units/mL of heparin were prepared by the addition of adequate amounts of azure A dye and heparin to distilled water. These heparin-dye assays solutions, when stored refrigerated, remain stable for a period of at least three months. From each assay solution, aliquots of 600 pL were drawn and transferred to a sequence of polypropylene tubes. To each tube, 400 pL of plasma containing increasing amounts of protamine were added. The absorbance in each tube was then measured at 620 nm against the reference sample which contained the same amount of heparin and azure A dye but no protamine. The standard curves thus prepared with final heparin concentrations of 2,3,6, and 9 units/ml were defined as the "2-", "3-", "6", and "Punit standard", respectively.
Validation of the Method for Protamine Qua&ation.
Two sets of test samples parallel in protamine concentrations ranging from 25 to 250 &mL were prepared from the same protamine stock solution (6 mg/mL) using adequate dilutions. These two sets of samples were prepared in exactly the same way except that one set utilized water and the other set utilized plasma as the dilution vehicle. Protamine concenuations in aqueous samples were then determined by the Lowry method (4), while protamine concentrations in plasma samples were determined by the dye method. Each concentration measurement was performed in triplicate. To perform the dye method, 400 pL of test samples with protamine concentrations in the range of O-40,40-90,90-175, and 175-250 ug/mL were added to 600 tiL assay solutions containing 3.3,5, 10, and 15 units/mL of heparin, respectively. All the assay solutions contained 80 ug/mL of azure A dye. Protamine concentrations in the above four concentration ranges were then determined using the "2-l', " 3-l', "6-", and "9-unit" standard curves, respectively. Both the test protamine samples and the standard curves were prepared with plasma obtained from the same &nor. The two protamine quantitation methods were compared statistically using the method-comparison procedures described by Westgard and Hunt (8) . Linear regression analysis was performed to estimate the accuracy, constant and proportional errors of the method. For linear regressions we used the averaged values from the comparison methods as the kkpendent variable.
The Eff'ect of Sample Variation on the Slope of the Standard Curve.
The "3-u& standard" was performed on seven plasma samples obtained from the American Red Cross from completely different donors. The slope of each curve was determined and statistically compared.
Detem'nation that the Method iUeasura Promnine Excess.
F%otamine excess is defined as the excess amount of free protamine that remains in the heparinkd sample after all the heparin in the sample is neutral&d by protamine. To determine whether the method measures the total protamine added or only the pro&mine excess, 216 pg of protamine were added to 2 mL of plasma sample pre-treated with 6 units of heparin. Four hundred microlitres of the sample were then added to 600 & of assay solution containing 80 &nL of axure A dye and 5 units,knL of heparin, and the protamine content was measured using the "Zunit standard". A standard protamine titration using procedures described in a previous publication (7) was performed on the original hep arinized sample to determine the equivalent value of heparin neutralization with protamine. Each experiment was performed in triplicate.
RESULTS
In Figure 1 are the standard curves constructed with fmal heparin concentrations of 3,6, and 9 units/ml. Each curve is characterized by a sigmoid shape which contains a well-defined linear region sandwiched by two (a lower and an upper) plateaus. In the lower plateau region, the protamine levels in the samples are too low relative to heparin, and thus insufficient amounts of dye are displaced from the heparindye complex. is present in large excess so that the In the upper plateau region, however, pmtamine maximum amount of dye is replaced from the heparin-dye complex and into the solution. The linear region of the curve represents the assay range of the method. It should be noted that the intercepts of the linear region with the two plateaus reflect the two detection limits (i.e. the lower and upper limits), whereas the slope of the linear region represents the sensitivity of the method. In creasing heparin concentration in the final assay mixture from 3 to 9 units/ml results in a shift of the detection limits towards higher protamine concentrations, in conjunction with a concomitant slight reduction of the slope from 0.290 to 0.250. These results suggest that when samples with higher prommine concentrations are assayed, higher heparin levels in the assay solution may be needed, although this could result in reduction of the sensitivity of the method.
As seen in Figure 2 , the method compares favorably with the conventional Lowry protein assay, despite that the method measures plasma protamine levels whereas the Lowry assay measures protamine in aqueous samples. The slope and y-intercept, as estimated by the least-squares fitting with a correlation coefficient of 0.992, are 0.940 and 1.9 &mL, respectively, indicating that the proportional error of the method is 6.0% and the constant error is 1.9 &nL.
For a protamine concentration of 100 pg/mL by the Lowry assay, the dye method yields a mean value of 96.0 t.&nL, and the 95% confidence interval would be 93.5 -98.5 &nL. In Table I is a summary of the data of slopes of the 3-unit standard curves prepared on seven different plasma specimens. The slopes appear to be consistent over various plasma samples tested, with a mean value of 0.0258 and a standard deviation of 0.0016.
In the heparinized plasma sample, the method apparently measures the remaining protamine level after heparin neutralization (i.e. the protamine excess), rather than the total protamine content in the sample. When 216 pg of protamine were added to a sample containing 6 units of heparin, the protamine level determined by the method using a 3-unit standard curve was only 152.8 pg. Calculation ftom the difference in pmtamine content yielded a pmtamme/heparin neuualization ratio of 10.5 &unit. This value is consistent with that of 10.3 + 0.5 ug/unit obtained from the protamine titration experiments using the procedures described previously (7) and the same batch of protamine and heparmized plasma. In addition, when 14.5 units of heparin (estimated from the protamine content of 152.8 pg and using the above neutralization ratio of 10.5 pg/unit) were added to back-titrate the protamine excess, the plasma aPIT was increased from the normal clotting time of 33.5 + 0.5 seconds to 38.2 f. 1.03 seconds. Estimation made from a heparin-aBIT standard curve (prepared on plasma from the same donor) indicated that such an aPTT value (i.e. 38.2 seconds) was equivalent to a heparin level (due to over titration) of 0.5 + 0.1 units. Based on this neutralization study, a protamine level of 147.2 pg (as compared to the level of 152.8 ug measured by the dye method) was calculated to be present in the "protamine excess" sample. These results all confirm the hypothesis that the method measures protamine excess.
DISCUSSION
Protamine is a strongly cationic polypeptide that is used regularly following cardiopulmonary bypass to neutralize the anticoagulant effect of heparin. Because an excess of protamine is necessary to maintain heparin inactivation, insufficient protamine may result in "hepsrin rebound", leading to postoperative bleeding (9). Conversely, too great an excess may cause adverse hemodynamic responses ranging from mild hypotension to severe, or ultimately fatal cardiovascular collapse (10) . Inasmuch as protamine, itself, has anticoagulant properties (11, 12) , a large excess may also enhance bleeding. Unfortunately, due to the lack of a specific method for the quantitation of protamine in plasma, the minimum and most effective protamine dose required to maintain neutralization of heparin has never been successfully determmed.
Azure A dye is known to undergo a shift of its adsorption spectrum from blue to purple in the presence of heparin (6) . Indeed, this unique metachtomatic characteristic of azure A dye has been used to measure the chemical quantities of heparin in plasma samples (13) . Since the binding between azure A and heparin is reversible and being relatively weak compared to that between protamine and heparin, when protamine is added to the heparin-azure A dye complex, it will displace azure A dye from the complex and subsequently restore the dye's original adsorption spectrum. Based on this competitive binding displacement mechanism, and also on the clinical specificity of protamine as heparin antagonist, we have developed a calorimetric method that is specific to measure plasma protamine levels. The plasma protamine levels determined by this dye method am within 94% of accuracy when compared with their aqueous counv determined by the conventional Lowry protein assay.
In the method presented, a plasma volume of 400 pL and a total azure A dye content of 48 p.g were used for the method. Although theoretically the application of a larger sample volume and/or higher dye content would improve the detection limit of the method., they would also introduce a higher turbidity (due to plasma) and background absorbance (due to azure A dye) to the sample. Based on our results (data are not shown), a plasma volume ranging from 300-400 NIL and a dye content ranging from 40-50 ug seem to be the optimum values.
Determination of an adequate standard curve for protamine quantitation is possibly the most difficult part for the method. In order for the method to function accurately, the linear region of the standard curve must fully cover the protamine concentrations to be measured. An approach is suggested herein which could facilitate the screening process for the most adequate standard curve. The approach calls for the addition of an excessive amDunt of heparin (e.g. 10 units) and protamine (e.g. 150 ug) to two separate test samples before mixing theses test samples (400 pL) with an assay mixture (600 uL) containing heparin (5 units/ml) and azure A dye (80 ug/mL). The absorbance in these samples are measured at 620 run and used as two-extremes. To screen for the most adequate standard curve, 400 pL of the test plasma samples are added to 600 uL of the assay mixtures containing different standard heparin concentrations (i.e. ranging from 3.3 to 15 units/ml as described in the h4ETHOD). The heparin-containing assay mixture which provides a linear absorbance range that falls best within the aforementioned two absorbance extremes would be the one that yields the most adequate standard curve.
In theory, there should be no limits with regard to how much heparin can be used in the assay mixture. The lower/higher the protamine content, the lower/higher the heparin concentration is required in the assay mixture. In practice, however, final heparin concentrations of 2 and 9 units/ml are set as the lower and upper limits, respectively, for the method. Heparin concentrations below 2 units/mL would produce an insufficient metachromatism, while above 9 units/ml cause the formation of turbid heparin-protamine precipitates due to the presence of high levels of the compounds.
The method proves to measure the "free" protamine level after heparin neutralization (i.e. protamine excess), rather the total added dose of protamine. This behavior is somewhat anticipated, since only free protamine would have the ability to bind with heparin and thus replace azure A dye from the heparin-dye complexes. Because of this behavior, it is conceivable to employ the method during clinical reversal of heparin with pmtamine to monitor protamine excess. Studies in this direction are currently in progress, as am experiments aimed at gaining more insight into the effects of pro&mine excess, using clinical samples obtained from patients undergoing cardiopulmonary bypass who have received heparin and subsequent reversal with protamine. Preliminary results seem to confirm the method in measuring protamine excess, although the excess amount of protamine estimated by the method is considerably lower than that calculated by the administered heparin and protamine doses. previous experiments involving dogs indicated that a significant amount of intravenous protamine disappeared during the in &Q studies, possibly due to its binding to endothelium cells (data are not shown).
The non-variability of the slope of the standard curve versus different plasma samples should provide an important and also beneficial feature towards both the ongoing clinical studies and the practical applicability of the method, In order for the method to measure protamine accurately, a standard curve must be prepared on plasma samples containing no heparin. Given the possibility that during an operational procedure the original plasma samples might not have been obtained prior to the hepariniza tion of the patient, this invariable property would allow pro&mine levels to be determined using a standard curve prepared on a different plasma, The method may also assist in ascribing the clinical cause of the "heparin rebound" phenomenon (14) . Shanberge and co-workers have suggested that the production of heparin rebound following heparin neutralixation with protamine may be associated to the loss of protamine excess (9) . Since the method measutes pmtamine excess, it may help confirm such a hypothesis.
Lastly, because the method can precisely measure protamine in a rather complex medium (e.g. plasma), it may be used as a tool for the quality control during the preparation of protamine injectables, or for monitoring ptotamine during its isolation and purification process.
